Qiagen Manchester Limited

Qiagen Manchester Limited, based in Manchester, UK, is a substantial player in the biotechnology sector, operating as a holding company with an active status. Established 24 years ago in February 2001, the company employs 261 people and holds assets valued at £27,766,445. It’s a real address, with four directors and one owner reported, and boasts a stellar 5.0 Google rating from four reviews. The company regularly imports and exports machinery, boilers, and mechanical appliances; parts, with 84 months of import activity and 48 months of export activity.

The company's website describes Qiagen Manchester Limited as a co-developer and marketer of companion diagnostics for the pharmaceutical industry, supporting cancer therapy development. It also provides pharmacogenomic services and licenses its “Scorpions” technology. The business operates within the research and experimental development on biotechnology and other human health activities industries.

Financially, Qiagen Manchester Limited presents a mixed picture. Current assets remained stable at £28 million, while net assets decreased by 3.5% to £25 million. Bank borrowings increased by 14%, reaching £29 million, and cash reserves decreased by 11% to £28 million. Creditors decreased by 18%, suggesting improved debt management. The company’s size (meeting two of three criteria for a large company) demonstrates its significant scale. While no auditor is mentioned, the financial statements are audited.

The company’s substantial asset base and ongoing import/export activity suggest a stable business, though the decrease in net assets warrants further investigation. The company’s focus on diagnostics and licensing, combined with its established presence, positions it well for future growth within the biotechnology market.

Registered in England/Wales under the registration number 04160032, with a registered address at M13 0BH, England, Manchester, Citylabs 2.0 Hathersage Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.